Baidu
map
J IMMUNOTHER CANCER 润色咨询

Journal for ImmunoTherapy of Cancer

出版年份:暂无数据 年文章数:2133 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:5.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

投稿信息

投稿信息
审稿费用
2500.0元/篇 (网友贡献,非官方数据)
版面费用
2650.0元/篇 (网友贡献,非官方数据)
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
5.6 %
年文章数
2133
期刊官网
点击查看 (点击次数:6301)
点击查看 (点击次数:5258次)
作者需知
点击查看 (点击次数:3593次)
期刊简介
稿件收录要求

Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed journal that publishes on all aspects of tumor immunology and cancer immunotherapy, aiming to enrich communication and advance scientific understanding in this rapidly evolving field. Topics of interest range across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity. 

Journal information

Publication Model
Open access
Frequency
Continuous
Launch date
2013
Digital Archives
Indexed by
Web of Science Core Collection: Science Citation Index Expanded; MEDLINE (Index Medicus), PubMed Central, Scopus, DOAJ, Google Scholar
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Print ISSN
N/A
Online ISSN
2051-1426

Journal Statistics 2023

Acceptance rate: 21%
 
Speed Time to first decision without review: 6 days (median) Time to first decision with review: 43 days (median) Time from acceptance to publication: 26 days (median)
Impact Impact Factor (JCR): 10.9 Impact Factor rank : 29/241 (Oncology), 18/161 (Immunology) 5 Year Impact Factor: 12.6 Journal Citation Indicator: 1.87 Eigenfactor: 0.04859 Citescore: 16.8 Citescore rank: 26/366 Scimago Journal rank (SJR): 3.403
Reach Total content views: 987,270 Total Altmetric mentions: 6,350
Baidu
map
Baidu
map
Baidu
map